Publications by authors named "R Pontier-Bres"

Article Synopsis
  • - The study investigates the differences between inflammatory osteoclasts and normal (steady-state) osteoclasts, identifying specific traits and key receptors that regulate these cells during chronic inflammation.
  • - Researchers found that the yeast probiotic CNCM I-745 can reduce bone loss in mice with inflammation by targeting the generation of inflammatory osteoclasts.
  • - The findings suggest that certain receptors linked to yeast recognition (Tlr2, Dectin-1, Mincle) play a significant role in the differentiation of inflammatory osteoclasts, offering potential new treatments for conditions involving bone loss.
View Article and Find Full Text PDF

A crucial phase in the infection process, which remains poorly understood, is the localization of suitable host cells by bacteria. It is often assumed that chemotaxis plays a key role during this phase. Here, we report a quantitative study on how Salmonella Typhimurium search for T84 human colonic epithelial cells.

View Article and Find Full Text PDF

Background And Aim: Chemotherapy drugs that act via Toll-like receptors (TLRs) can exacerbate mucosal injury through the production of cytokines. Intestinal mucositis can activate TLR2 and TLR4, resulting in the activation of NF-κB. Intestinal mucositis characterized by intense inflammation is the main side effect associated with 5-fluorouracil (5-FU) treatment.

View Article and Find Full Text PDF

Intestinal mononuclear phagocytes (MPs) comprise dendritic cells (DCs) and macrophages (Mφs) that play different roles in response to infection. After phagocytosis, DCs expressing CD103 transport from the intestinal tract to the mesenteric lymph nodes (MLN) and induce adaptive immune responses whereas resident Mφs expressing CX3CR1 capture bacteria in the lumen and reside in the (LP) where they induce a local immune response. CX3CR1 Mφs are generated from Ly6C monocytes that enter the colonic mucosa and differentiate locally.

View Article and Find Full Text PDF

The probiotic yeast Saccharomyces boulardii (S. boulardii) has been prescribed for the prophylaxis and treatment of several infectious diarrheal diseases. Gastrointestinal anthrax causes fatal systemic disease.

View Article and Find Full Text PDF